Global Clinical Trial Supplies Market to Reach $3.3 Billion by 2030
The global market for Clinical Trial Supplies estimated at US$2.4 Billion in the year 2023, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Phase I Clinical Trial Supplies, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$499.1 Million by the end of the analysis period. Growth in the Phase II Clinical Trial Supplies segment is estimated at 4.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $728.4 Million, While China is Forecast to Grow at 4.5% CAGR
The Clinical Trial Supplies market in the U.S. is estimated at US$728.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$587.4 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook